Lower-middle income (World Bank) vs Panama: HIV-positive TB patients on ART (antiretroviral therapy)
Lower-middle income (World Bank)
95.0%
in 2024
Panama
100.0%
in 2024
Lower-middle income (World Bank) rank
3rd
Panama rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Lower-middle income (World Bank)
- Panama
How they compare
Panama currently reports 100.0% against 95.0% in Lower-middle income (World Bank), a difference of 5.0%.
That makes Panama's figure about 1.1 times Lower-middle income (World Bank)'s.
The two have swapped places 5 times across 21 shared years of data; in 2004 it was Lower-middle income (World Bank) ahead.
Lower-middle income (World Bank) ranks 3rd and Panama ranks 1st of 11 groups.
Across the 3 decades both report, Lower-middle income (World Bank) averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Lower-middle income (World Bank) | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 34.5% | 25.0% | 9.5% | Lower-middle income (World Bank) |
| 2010s | 75.8% | 95.4% | 19.6% | Panama |
| 2020s | 94.0% | 95.8% | 1.8% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Lower-middle income (World Bank) or Panama?
- Panama, at 100.0% against 95.0% in Lower-middle income (World Bank) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Lower-middle income (World Bank) and Panama?
- 5.0%, with Panama ahead.
- How many years of comparable data are there for Lower-middle income (World Bank) and Panama?
- 21 years are reported by both, from 2004 to 2024.
- How do Lower-middle income (World Bank) and Panama rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Lower-middle income (World Bank) ranks 3rd and Panama ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.